Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars V Kessing

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Bipolar Disorders|April 27, 2019
Lithium and bipolar depressionMirko Manchia, Janusz K Rybakowski, Gabriele Sani, et al.
Brain, Behavior, and Immunity|December 19, 2022
Persistent increase over time in oxidatively stress generated RNA and DNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives - An up to 5-year prospective studyKlara Coello, Julie Lyng Forman, Helle Holstad Pedersen, et al.
Journal of Psychopharmacology (Oxford, England)|July 5, 2018
Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorderJulian Macoveanu, Kirsa M Demant, Maj Vinberg, et al.
Bipolar Disorders|March 16, 2019
New drug candidates for bipolar disorder-A nation-wide population-based studyLars V Kessing, Helene C Rytgaard, Thomas A Gerds, et al.
Psychotherapy and Psychosomatics|May 28, 2016
Angiotensin Converting Enzyme Inhibitors and Risk of Mood DisordersLana J Williams, Julie A Pasco, Lars V Kessing, et al.
Bipolar Disorders|October 14, 2020
Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trialCaroline V Ott, Maj Vinberg, Lars V Kessing, et al.
Nordic Journal of Psychiatry|January 12, 2016
Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trialUlla Knorr, Pernille Koefoed, Christian Gluud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort StudyNis P Suppli, Christoffer Johansen, Lars V Kessing, et al.
International Journal of Bipolar Disorders|April 3, 2019
Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relativesKlara Coello, Maj Vinberg, Filip K Knop, et al.
Journal of Psychopharmacology (Oxford, England)|November 28, 2024
Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trialJulian Macoveanu, Jeff Zarp, Maj Vinberg, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Bipolar Disorders|April 27, 2019
Lithium and bipolar depressionMirko Manchia, Janusz K Rybakowski, Gabriele Sani, et al.
Brain, Behavior, and Immunity|December 19, 2022
Persistent increase over time in oxidatively stress generated RNA and DNA damage in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives - An up to 5-year prospective studyKlara Coello, Julie Lyng Forman, Helle Holstad Pedersen, et al.
Journal of Psychopharmacology (Oxford, England)|July 5, 2018
Towards a biomarker model for cognitive improvement: No change in memory-related prefrontal engagement following a negative cognitive remediation trial in bipolar disorderJulian Macoveanu, Kirsa M Demant, Maj Vinberg, et al.
Bipolar Disorders|March 16, 2019
New drug candidates for bipolar disorder-A nation-wide population-based studyLars V Kessing, Helene C Rytgaard, Thomas A Gerds, et al.
Psychotherapy and Psychosomatics|May 28, 2016
Angiotensin Converting Enzyme Inhibitors and Risk of Mood DisordersLana J Williams, Julie A Pasco, Lars V Kessing, et al.
Bipolar Disorders|October 14, 2020
Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trialCaroline V Ott, Maj Vinberg, Lars V Kessing, et al.
Nordic Journal of Psychiatry|January 12, 2016
Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trialUlla Knorr, Pernille Koefoed, Christian Gluud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Survival After Early-Stage Breast Cancer of Women Previously Treated for Depression: A Nationwide Danish Cohort StudyNis P Suppli, Christoffer Johansen, Lars V Kessing, et al.
International Journal of Bipolar Disorders|April 3, 2019
Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relativesKlara Coello, Maj Vinberg, Filip K Knop, et al.
Journal of Psychopharmacology (Oxford, England)|November 28, 2024
Exploring the effects of erythropoietin treatment on cortical thickness and hippocampal volume in patients with mood disorders undergoing electroconvulsive therapy: A randomized, placebo-controlled trialJulian Macoveanu, Jeff Zarp, Maj Vinberg, et al.
Pageof 12